All Stories

  1. Widespread expression of the ancient HERV-K (HML-2) provirus group in normal human tissues
  2. HIV proviral DNA integration can drive T cell growth ex vivo
  3. Mechanisms of HERV-K (HML-2) Transcription during Human Mammary Epithelial Cell Transformation
  4. RNA editing, epitranscriptomics, and processing in cancer progression
  5. A Mouse Strain Defective in Both T Cells and NK Cells Has Enhanced Sensitivity to Tumor Induction by Plasmid DNA Expressing Both Activated H-Ras and c-Myc
  6. The distribution of insertionally polymorphic endogenous retroviruses in breast cancer patients and cancer-free controls
  7. HIV-1 Infection Leads to Increased Transcription of Human Endogenous Retrovirus HERV-K (HML-2) Proviruses In Vivo but Not to Increased Virion Production
  8. PAPNC, a novel method to calculate nucleotide diversity from large scale next generation sequencing data
  9. Retrovirus Variation and Evolution
  10. Lack of Detectable HIV-1 Molecular Evolution during Suppressive Antiretroviral Therapy
  11. Endogenous Retroviruses and Human Cancer: Is There Anything to the Rumors?
  12. Fifteen Years Later: Hard and Soft Selection Sweeps Confirm a Large Population Number for HIV In Vivo
  13. False-Positive HIV PCR Test Following Ex Vivo Lentiviral Gene Transfer Treatment of X-linked Severe Combined Immunodeficiency Vector
  14. The distribution of insertionally polymorphic endogenous retroviruses in breast cancer patients and cancer-free controls
  15. A Novel Recombinant Retrovirus in the Genomes of Modern Birds Combines Features of Avian and Mammalian Retroviruses
  16. Single Cell Analysis of Lymph Node Tissue from HIV-1 Infected Patients Reveals that the Majority of CD4+ T-cells Contain One HIV-1 DNA Molecule
  17. Virions at the Gates: Receptors and the Host–Virus Arms Race
  18. Analysis of 454 sequencing error rate, error sources, and artifact recombination for detection of Low-frequency drug resistance mutations in HIV-1 DNA
  19. HIV Population Dynamics
  20. Betaretroviral Envelope Subunits Are Noncovalently Associated and Restricted to the Mammalian Class
  21. HIV-1 Pathogenesis: The Virus
  22. A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus
  23. Ultrasensitive Allele-Specific PCR Reveals Rare Preexisting Drug-Resistant Variants
  24. Recombinant origin, contamination, and de-discovery of XMRV
  25. Studies on the Restriction of Murine Leukemia Viruses by Mouse APOBEC3
  26. Multiple Sources of Contamination in Samples from Patients Reported to Have XMRV Infection
  27. Restricted Replication of Xenotropic Murine Leukemia Virus-Related Virus in Pigtailed Macaques
  28. From XMRV to HIV-1 and back
  29. Characterization, mapping and distribution of the two XMRV parental proviruses
  30. Amplifying and Quantifying HIV-1 RNA in HIV Infected Individuals with Viral Loads Below the Limit of Detection by Standard Clinical Assays
  31. Correction: The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
  32. Multi-laboratory evaluations of XMRV nucleic acid detection assays
  33. The Blood Xenotropic Murine Leukemia Virus-Related Virus Scientific Research Working Group: mission, progress, and plans
  34. Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses
  35. Binding of more than one Tva800 molecule is required for ASLV-A entry
  36. Endogenous Murine Leukemia Viruses: Relationship to XMRV and Related Sequences Detected in Human DNA Samples
  37. ART did not decrease genetic diversity of RT-SHIV
  38. The Effect of Raltegravir Intensification on Low-level Residual Viremia in HIV-Infected Patients on Antiretroviral Therapy: A Randomized Controlled Trial
  39. Patterns of Human Immunodeficiency Virus Type 1 Recombination Ex Vivo Provide Evidence for Coadaptation of Distant Sites, Resulting in Purifying Selection for Intersubtype Recombinants during Replication
  40. Multi-site adaptation in the presence of infrequent recombination
  41. Interpreting the effect of vaccination on steady state infection in animals challenged with Simian immunodeficiency virus
  42. CPSF6 binds HIV-1 capsid and cytoplasmic expression restricts infection
  43. Optimization of allele-specific PCR using patient-specific HIV consensus sequences for primer design
  44. Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection
  45. Low Frequency Nonnucleoside Reverse‐Transcriptase Inhibitor–Resistant Variants Contribute to Failure of Efavirenz‐Containing Regimens in Treatment‐Experienced Patients
  46. Endogenous non-retroviral RNA virus elements in mammalian genomes
  47. Mouse DNA contamination in human tissue tested for XMRV
  48. Contamination of human DNA samples with mouse DNA can lead to false detection of XMRV-like sequences
  49. RT-SHIV subpopulation dynamics in infected macaques during anti-HIV therapy
  50. A New Virus for Old Diseases?
  51. Persistent Low‐Level Viremia in HIV‐1 Elite Controllers and Relationship to Immunologic Parameters
  52. Evaluation of the Pathogenesis of Decreasing CD4 + T Cell Counts in Human Immunodeficiency Virus Type 1–Infected Patients Receiving Successfully Suppressive Antiretroviral Therapy
  53. Likely Role of APOBEC3G-Mediated G-to-A Mutations in HIV-1 Evolution and Drug Resistance
  54. Regimen Simplification to Atazanavir‐Ritonavir Alone as Maintenance Antiretroviral Therapy: Final 48‐Week Clinical and Virologic Outcomes
  55. Human Immunodeficiency Virus Type 1 Population Genetics and Adaptation in Newly Infected Individuals
  56. Effects of Retroviruses on Host Genome Function
  57. Attenuation by a Thousand Cuts
  58. Host-Retrovirus Arms Race: Trimming the Budget
  59. Detection of Nonnucleoside Reverse‐Transcriptase Inhibitor–Resistant HIV‐1 after Discontinuation of Virologically Suppressive Antiretroviral Therapy
  60. Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cells
  61. Frequent polymorphism at drug resistance sites in HIV-1 protease and reverse transcriptase
  62. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction
  63. Study of RT inhibitor resistance in a macaque model of HIV/AIDS
  64. Retroviruses and AIDS: evolution and drug resistance
  65. Role of APOBEC3 in Genetic Diversity among Endogenous Murine Leukemia Viruses
  66. ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia
  67. Selection and persistence of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 in patients starting and stopping non-nucleoside therapy
  68. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study
  69. Characterization of Hortulanus Endogenous Murine Leukemia Virus, an Endogenous Provirus That Encodes an Infectious Murine Leukemia Virus of a Novel Subgroup
  70. Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites
  71. Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis
  72. Role of APOBEC3 in Genetic Diversity among Endogenous Murine Leukemia Viruses
  73. SIV containing HIV-1 RT can be inhibited by anti-HIV-1 RT inhibitors
  74. Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome
  75. New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma
  76. A Novel Endogenous Retrovirus-Related Element in the Human Genome Resembles a DNA Transposon: Evidence for an Evolutionary Link?
  77. Mouse Mammary Tumor Virus Superantigen Expression Is Reduced by Glucocorticoid Treatment
  78. The Mouse Mammary Tumor Virus Transcription Enhancers for Hematopoietic Progenitor and Mammary Gland Cells Share Functional Elements
  79. Proposed alternatives for the use of anti-HIV drugs: is it appropriate?
  80. Book Review Microbe Hunters — Then and now Edited by Hilary Koprowski and Michael B.A. Oldstone. 456 pp., illustrated. Bloomington, Ill., Medi-Ed Press, 1996. $45. 0-936741-11-2
  81. Workshop Summary : Workshop on Perinatally Acquired Human Immunodeficiency Virus Infection in Long-Term Surviving Children: A Collaborative Study of Factors Contributing to Slow Disease Progression
  82. Retrovirus restriction revealed
  83. The dangers of xenotransplantation
  84. Stimulation of mouse mammary tumor virus superantigen expression by an intragenic enhancer.
  85. Lines drawn in epitope wars
  86. Multifactorial inheritance of neural tube defects: localization of the major gene and recognition of modifiers in ct mutant mice
  87. How does variation count?
  88. Mapping of the motor neuron degeneration (Mnd) gene, a mouse model of amyotrophic lateral sclerosis (ALS)
  89. Mechanism of transduction by retroviruses
  90. Superantigens and endogenous retroviruses: a confluence of puzzles
  91. Structure and Classification of Retroviruses
  92. Characterization of the endogenous nonecotropic murine leukemia viruses of NZB/BINJ and SM/J inbred strains
  93. Book Review Virus Hunting: AIDS, cancer, and the human retrovirus By Robert Gallo. 352 pp., illustrated. New York, Basic Books, 1991. $22.95.
  94. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice
  95. Isotype switching of an immunoglobulin heavy chain transgene occurs by DNA recombination between different chromosomes
  96. Molecular mechanisms of nucleic acid integration
  97. The virology of AIDS
  98. Genetic Variation in Retroviruses
  99. Determination of 3′ end processing in retroelements
  100. Genetics of Endogenous Murine Leukemia Viruses
  101. Too high a price
  102. Role of endogenous retroviruses as mutagens: The hairless mutation of mice
  103. Highly preferred targets for retrovirus integration
  104. Rous sarcoma virus is integrated but not expressed in chicken early embryonic cells.
  105. Genetic variation in AIDS viruses
  106. Microbiology: The Microbe 1984.
  107. Genomes of endogenous and exogenous avian retroviruses
  108. VARIATION IN AVIAN RETROVIRUS GENOMES
  109. Structural Analysis of Retrovirus Genomes
  110. VIRAL ENVELOPE GENES AND c REGIONS IN NON-ACUTE AVIAN LEUKOSIS VIRUS ASSOCIATED DISEASE
  111. SYNTHESIS AND PROCESSING OF THE INTERNAL STRUCTURAL PROTEINS OF RETROVIRUSES: SITE OF SYNTHESIS, EVIDENCE FOR MULTIPLY-CHARGED SPECIES, AND ANALYSIS OF A MUTANT DEFECTIVE IN PROCESSING11This research supported by grants from the National Cancer Institu...
  112. Subgroup-E Avian-leukosis-virus-associated Disease in Chickens
  113. Recombination between the defective component of an acute leukemia virus and Rous associated virus O, an endogenous virus of chickens.
  114. In Vitro Studies of the Replication of Moloney Murine Leukemia Virus
  115. Recombinant avian oncoviruses I. Alterations in the precursor to the internal structural proteins
  116. Structure of the genome of moloney murine leukemia virus: a terminally redundant sequence
  117. Nucleotide sequence of Rous sarcoma virus RNA at the initiation site of DNA synthesis
  118. The genome of Uukuniemi virus consists of three unique RNA segments
  119. Terminal redundancy and the origin of replication of Rous sarcoma virus RNA.
  120. A physical map of the Rous sarcoma virus genome
  121. The Nucleotide Sequence Complexity of Avian Tumor Virus RNA
  122. In Vitro Synthesis of Rous Sarcoma Virus-Specific RNA is Catalyzed by a DNA-Dependent RNA Polymerase
  123. A new approach to the isolation of RNA-DNA hybrids and its application to the quantitative determination of labeled tumor virus RNA
  124. Retroviruses